KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

UiPath (PATH) Research & Development (2020 - 2026)

UiPath filings provide 7 years of Research & Development readings, the most recent being $95.2 million for Q1 2026.

  • Quarterly Research & Development fell 4.53% to $95.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $385.2 million through Jan 2026, up 1.19% year-over-year, with the annual reading at $385.2 million for FY2026, 1.19% up from the prior year.
  • Research & Development hit $95.2 million in Q1 2026 for UiPath, down from $96.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $99.7 million in Q1 2025 and bottomed at $64.4 million in Q1 2022.
  • Average Research & Development over 5 years is $85.2 million, with a median of $85.6 million recorded in 2024.
  • Peak annual rise in Research & Development hit 120.63% in 2022, while the deepest fall reached 26.17% in 2022.
  • UiPath's Research & Development stood at $67.3 million in 2022, then grew by 25.5% to $84.5 million in 2023, then grew by 14.75% to $97.0 million in 2024, then dropped by 0.11% to $96.9 million in 2025, then dropped by 1.77% to $95.2 million in 2026.
  • Per Business Quant, the three most recent readings for PATH's Research & Development are $95.2 million (Q1 2026), $96.9 million (Q4 2025), and $98.3 million (Q3 2025).